
Daniel J. George, MD, Duke Cancer Institute
Advertisement
Articles by Daniel J. George, MD, Duke Cancer Institute












Advertisement
Latest Updated Articles
FDA Approved Agents for Non-Metastatic CRPCJuly 9th 2020
Conventional Versus PSMA Imaging in Prostate CancerJuly 9th 2020
The CARD and PROfound Trials for Metastatic CRPCJuly 9th 2020
Emerging Therapies for Advanced Prostate CancerJuly 9th 2020
Impact of Clinical Data on the Treatment of mCRPCJuly 9th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Pimicotinib for Symptomatic TGCT
2
Mo-Rez Responses Span B7-H4 Expression Levels in Platinum-Resistant Ovarian Cancer in BEHOLD-1 Biomarker Analysis
3
Genomic Testing, Toxicity, and Sequencing Shape Treatment Decisions in Advanced Prostate Cancer
4
Dr Natsuhara on Treatment Advances and Research Considerations in TNBC
5

